Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Humbert (Clamart, France). Presentation by an expert: Mast cells and c-kit positive cells in pulmonary arterial hypertension. Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease

Member's Comments

No comment yet.

Related content which might interest you: CD133+ cells in pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 459-469 Year: 2016 Implication of bone marrow-derived c-kit positive cells in idiopathic pulmonary arterial hypertension Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension Year: 2009 Circulating endothelial progenitor cells and CD45+ cells in pulmonary arteries of COPD patients Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Endothelial cells in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020 Year: 2021 CD163 is expressed and modulated in human pulmonary artery smooth muscle cells: Implications for pulmonary artery hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Increased Cyr61 in pulmonary arterial hypertension involving in proliferation of pulmonary arterial smooth muscle cells Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Increased regulatory T cells in the blood of patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006 Nuclear IL-33 arguments ST2 receptor expression in pulmonary arterial endothelial cells: Implication in the pathogenesis and progression of pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Pulmonary arterial hypertension and continuous injury of alveolar epithelial cells in COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Regulatory T cells in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Presentation by an expert: NK cells in lung inflammation Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 Characterization of circulating CD133+ progenitor cells in pulmonary arterial hypertension Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Distinct patterns of circulating endothelial cells in pulmonary hypertension Source: Eur Respir J 2010; 36: 1284-1293 Year: 2010 Roles of circulating and resident myeloid cell subpopulations in bronchopulmonary remodeling and pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 A central role for nuclear factor of activated T cells (NFAT) in human pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension Source: Eur Respir J 2007; 29: 462-468 Year: 2007